Funder: Breakthrough T1D
Due Dates: October 29, 2025 (webinar registration) | November 17, 2025 (LOI deadline) | January 27, 2026 (full proposal deadline)
Funding Amounts: Up to $900,000 total (including 10% indirect costs) over 3 years; for-profit awards may differ.
Summary: Supports research to understand and overcome the foreign body response to islet cell replacement devices, accelerating clinical translation for Type 1 Diabetes.